Cancer Keys: Thresholds for a Positive FIT Test in Symptomatic Patients

Latest from the Blog

World Cancer Day 2021

World Cancer Day 2021

4th February 2021 The 4th of February 2021 marks World Cancer Day 2021. This year, the theme #IAmAndIWill encourages us to recognise our own commitments to improving cancer outcomes. GatewayC now has over 19 free online cancer education courses which can help primary...

read more

Related Posts

Cancer Keys: COVID-19 and Neutropenic Sepsis

Cancer Keys: COVID-19 and Neutropenic Sepsis

Neutropenic sepsis is a potentially fatal complication of anticancer treatment (particularly chemotherapy). Helpful hint: NICE have produced a COVID-19 rapid guideline on the delivery of systemic anticancer treatments. If patients present with COVID-19 symptoms this...

read more

Potential pitfall:

A negative bowel screening test should not be used to make decisions about referral in a symptomatic patient. Sensitivity levels have been set very differently for screening and symptomatic Faecal Immunochemical Tests (FIT).

Helpful hint:

The screening sensitivity threshold is 120ug/g in England (150ug/g in Wales and 80ug/g in Scotland). In symptomatic patients, the NICE DG30 guidance recommends that results should be reported using a threshold of 10 micrograms of haemoglobin per gram of faeces.

Cancer Keys are brought to you by GatewayC.

Download this Cancer Key here

Read the NICE NG12 guidance here

Access GatewayC’s Faecal Immunochemical Test (FIT) course here

LinkedIn Twitter | Facebook

Latest from the Blog

World Cancer Day 2021

World Cancer Day 2021

4th February 2021 The 4th of February 2021 marks World Cancer Day 2021. This year, the theme #IAmAndIWill encourages us to recognise our own commitments to improving cancer outcomes. GatewayC now has over 19 free online cancer education courses which can help primary...

read more

Related Posts

Cancer Keys: COVID-19 and Neutropenic Sepsis

Cancer Keys: COVID-19 and Neutropenic Sepsis

Neutropenic sepsis is a potentially fatal complication of anticancer treatment (particularly chemotherapy). Helpful hint: NICE have produced a COVID-19 rapid guideline on the delivery of systemic anticancer treatments. If patients present with COVID-19 symptoms this...

read more